Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up

INTRODUCTION: This study compared the pharmacokinetics (PK) of the ravulizumab on-body delivery system for subcutaneous (SUBQ) administration with intravenous (IV) ravulizumab in eculizumab-experienced patients with paroxysmal nocturnal hemoglobinuria (PNH). METHODS: Patients with PNH received SUBQ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yenerel, Mustafa N., Sicre de Fontbrune, Flore, Piatek, Caroline, Sahin, Fahri, Füreder, Wolfgang, Ortiz, Stephan, Ogawa, Masayo, Ozol-Godfrey, Ayca, Sierra, J. Rafael, Szer, Jeff
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589670/
https://www.ncbi.nlm.nih.gov/pubmed/36272026
http://dx.doi.org/10.1007/s12325-022-02339-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589670/
https://www.ncbi.nlm.nih.gov/pubmed/36272026
http://dx.doi.org/10.1007/s12325-022-02339-3

Ejemplares similares